From Diabetes to Heart and Kidney Health: The Rise of SGLT2 Inhibitors

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
SGLT2 inhibitors were originally developed to manage type 2 diabetes, but their benefits go far beyond blood sugar control. In this video, Professor Peter Barlis explores how these medications are now transforming the way we treat heart failure and chronic kidney disease, even in people without diabetes.

Learn how SGLT2 inhibitors work, why cardiologists and nephrologists are increasingly prescribing them, and what the latest clinical trials reveal about their protective effects on the heart and kidneys.

Whether you're a patient, carer, or simply curious about the evolving role of these medications, this video offers an easy-to-understand overview backed by current evidence.

Subscribe to Heart Matters for clear, expert insights on heart health and beyond.

For more information, visit www.heartmatters.com
Category
Cardiology
Be the first to comment

Up Next